Relationship among genetic polymorphism of SLCO1B1 , rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis-Reference-Cited by-同舟云学术

Relationship among genetic polymorphism of SLCO1B1 , rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis

Published:2021-03-05 Issue:9 Volume:87 Page:3492-3500
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kim Eun Sun¹²^ORCID,Kwon Byoung Soo¹²,Park Jong Sun¹²,Chung Jae‐Yong³⁴^ORCID,Seo Soo Hyun⁵⁶,Park Kyoung Un⁵⁶,Song Junghan,Yoon Seonghae⁴,Lee Jae Ho¹²

Affiliation:

1. Department of Internal Medicine Seoul National University Bundang Hospital Seongnam South Korea

2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Seoul National University Bundang Hospital Seongnam South Korea

3. Department of Clinical Pharmacology and Therapeutics Seoul National University Bundang Hospital Seongnam South Korea

4. Clinical Trials Center Seoul National University Bundang Hospital Seongnam South Korea

5. Department of Laboratory Medicine Seoul National University College of Medicine Seoul Republic of Korea

6. Department of Laboratory Medicine Seoul National University Bundang Hospital Seongnam South Korea

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14758

Reference30 articles.

1. Organization WH.Global tuberculosis report 2020.2020.

2. Prevention KCfDCa.Annual Report on the Notified Tuberculosis Patients in Korea 2017. Accessed 1 September 2020.

3. Achievements in and Challenges of Tuberculosis Control in South Korea

4. Role of individual drugs in the chemotherapy of tuberculosis;Mitchison DA;Int J Tuberc Lung Dis,2000

5. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946‐1986, with relevant subsequent publications;Fox W;Int J Tuberc Lung Dis,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers;European Journal of Clinical Pharmacology;2024-05-09

2. Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure;International Journal of Antimicrobial Agents;2024-02

3. Genetic Variations of Angiotensinogen, Angiotensin Converting Enzyme, and Angiotensin Type 1 Receptor with the Risk of Pulmonary Tuberculosis;Prague Medical Report;2024

4. Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database;BMC Pulmonary Medicine;2023-11-24

5. Pharmacogenomics in Asians: Differences and similarities with other human populations;Expert Opinion on Drug Metabolism & Toxicology;2023-01-02